South Africa’s National Aids Council has launched a renewed effort to secure licences to make generic versions of lenacapavir in the country. This is how it is going about it.

RNA vaccines saved millions of lives during COVID-19 but have limitations like waning immunity and complex production. Scientists are now testing a new platform called DoriVac, which uses folded DNA ...

South Africa's National Aids Council, Sanac, has asked local drug companies to submit applications by April 7 to make generic versions of an anti-HIV jab that could end Aids by 2043 in the country.

Advancing HBV Functional Cure Toward Key Phase 2b Data ReadoutsIncreasing Discovery Efforts to Drive Long-term Value CreationStrong Cash Position ...

Health officials are racing to understand whether this dangerous variant of meningitis B has evolved in a way that allows it to spread more easily between people.

Health officials are racing to understand whether this dangerous variant of meningitis B has evolved in a way that allows it ...

For millions of people living with HIV, a daily regimen of medications is a lifelong necessity. If they stop taking the drugs—commonly referred to as antiretroviral therapy—the virus usually rushes ...

What are the three types of HIV tests available to patients, how do they differ, and how can patients determine the best ...

Cognitive aging in virally suppressed HIV parallels those without HIV, while detectable viral load is linked to steeper cognitive decline.

A new study published in The Lancet Microbe reports the first twice-yearly injectable HIV treatment regimen—combining lenacapavir, teropavimab, and zinlirvimab—has achieved high rates of viral ...

Long-acting injectable CAB+RPV maintains high virologic suppression in patients with HIV and obesity, showing comparable real-world efficacy.

ACB allegedly probing former HRDC chairperson Gift Trapence' wife Gertrude Lemani on MAREP contracts - The Maravi Post ...